市場調查報告書

婦產科診斷市場 - 成長,趨勢,預測

Women's Health Diagnostics Market - Growth, Trends, and Forecast (2020 - 2025)

出版商 Mordor Intelligence LLP 商品編碼 921274
出版日期 內容資訊 英文 111 Pages
商品交期: 2-3個工作天內
價格
婦產科診斷市場 - 成長,趨勢,預測 Women's Health Diagnostics Market - Growth, Trends, and Forecast (2020 - 2025)
出版日期: 2020年01月01日內容資訊: 英文 111 Pages
簡介

婦產科診斷市場,由於慢性疾病和文明病的發生率增加,影像診斷中心數的增加,照護現場和迅速診斷試驗的採用增加,顯示急速成長。

本報告提供婦產科診斷的世界市場調查,市場概要,各類型、終端用戶、地區的市場趨勢,市場規模的變化與預測,市場促進、阻礙因素以及市場機會分析,競爭情形,主要企業的簡介等全面性資訊。

目錄

第1章 簡介

  • 調查成果
  • 調查的前提條件
  • 調查範圍

第2章 調查手法

第3章 摘要整理

第4章 市場動態

  • 市場概要
  • 成長要素
  • 阻礙因素
  • 波特的五力分析
    • 新加入廠商的威脅
    • 消費者談判力
    • 供應商談判力
    • 替代產品的威脅
    • 產業內的競爭

第5章 市場區隔

  • 各類型
    • 診斷設備
    • 診斷試驗
  • 各適用
    • 乳癌
    • 傳染病檢查
    • 骨質疏鬆症檢驗
    • 妊娠與不孕檢驗
    • 性傳染病檢查
    • 其他
  • 各終端用戶
    • 醫院、診斷中心
    • 居家護理
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東、非洲
    • 南美

第6章 競爭情形

  • 企業簡介
    • Siemens AG
    • Quest Diagnostics Inc.
    • Hologic, Inc.
    • F. Hoffmann-La Roche AG
    • Perkinelmer Inc.
    • Alere Inc.
    • GE Healthcare
    • Becton, Dickinson and Company
    • Abbott Laboratories
    • Biomerieux SA
    • Koninklijke Philips NV

第7章 市場機會及未來趨勢

目錄
Product Code: 67170

Market Overview

The women's health diagnostics market will show rapid growth due to the rising incidence of chronic and lifestyle-related disorders, rising number of imaging and diagnostic centers and increased adoption of point-of-care and rapid diagnostic tests.

Women's health diagnostics market is growing due to the increasing prevalence of osteoarthritis, ovarian cancer, breast cancer, and cervical cancer. Breast cancer is the most commonly occurring cancer in women and the second most common cancer worldwide. There were around 2 million new cases found in 2018. The increasing cases have resulted in increased sales test kits for home usage that is also expected to drive the revenue growth of the market over the forecast period. Therefore the rise in the rate of adoption of point-of-care diagnostic testing and an increase in the number of diagnostic and imaging devices across the globe are expected to fuel the market growth.

On the other hand, the surge in demand for the development of miniature diagnostic devices, a rise in healthcare infrastructure, and new marketing initiatives by key vendors in emerging countries are expected to provide lucrative opportunities for the market expansion during the forecast period.

Scope of the Report

As per the scope of the report, women are considered to be more susceptible to certain disorders such as osteoporosis, menstrual disorders, cancer, and autoimmune diseases. The major diseases include menopause, infertility, polycystic ovarian syndrome, and certain cancers such as breast cancer, cervical cancer, as well as urological disorders. The rise in innovative solutions in women's health gives physicians the ability to provide the right treatment at the right time. From cervical cancer screening to support infertility, prenatal testing and pregnancy care to breast and ovarian cancer diagnosis to managing bone health, diagnostics play a major role in the market.

Key Market Trends

Diagnostic Tests Segment is Expected to Show the Largest Growth in the Type Segment During the Forecast Period

The diagnostic tests segment is accounted for the largest market share and is expected to remain so throughout the forecast period. The diagnostic tests involve various tests related to women's health such as pregnancy and ovulation tests, breast cancer tests, ovarian cancer tests, and others. There are also factors such as high adoption of point-of-care diagnostics, a rise in the prevalence of women's health-related disorders, and growth in awareness about various tests that drive the market for diagnostic tests.

There are also advancements seen in testing that keeps a check on women-centric conditions that include infectious diseases, osteoporosis, and breast cancer. This is estimated to work in favor of the market.

North America has Recorded the Largest Share During the Forecast Period

North America is expected to constitute a major market share owing to the high prevalence of cancer among women, rising incidence of lifestyle-related disorders. This can be attributed to the high adoption of technologically advanced products, product launches, and government initiatives. The presence of better healthcare infrastructure, rising awareness about women's health disorders and increased participation of women in the workforce are some of the other factors poised to positively influence the growth of the regional market.

Europe has been the second-largest market for women's health diagnostics due to the presence of a large pool of cancer patients, increasing healthcare expenditure and rapidly developing healthcare infrastructure.

Competitive Landscape

There has been the presence of a large number of companies that are significantly contributing to market growth. Some of the major players are Siemens Healthcare Private Limited, Hologic, Inc., GE Healthcare, F.Hoffmann-La Roche Ltd., and Koninklijke Philips N.V. amongst others. These companies' new product developments, mergers, and acquisitions are some of the strategies undertaken by these companies to strengthen their market presence.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Incidence of Chronic and Lifestyle-Related Disorders
    • 4.2.2 Rising Number of Imaging and Diagnostic Centres
    • 4.2.3 Increased Adoption of Point-Of-Care and Rapid Diagnostic Tests
  • 4.3 Market Restraints
    • 4.3.1 High Cost of Diagnostic Imaging Systems
    • 4.3.2 Stringent Regulatory Guidelines
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Type
    • 5.1.1 Diagnostic Devices
      • 5.1.1.1 Biopsy Devices
      • 5.1.1.2 Imaging and Monitoring System
      • 5.1.1.3 Others
    • 5.1.2 Diagnostic Tests
      • 5.1.2.1 Breast Cancer Testing
      • 5.1.2.2 PAP Smear (PAP) and HPV Test
      • 5.1.2.3 Pregnancy Testing and Ovulation Testing
      • 5.1.2.4 Others
  • 5.2 By Application
    • 5.2.1 Breast Cancer
    • 5.2.2 Infectious Disease Testing
    • 5.2.3 Osteoporosis Testing
    • 5.2.4 Pregnancy and Fertility Testing
    • 5.2.5 Sexually Transmitted Disease Testing
    • 5.2.6 Others
  • 5.3 By End User
    • 5.3.1 Hospital and Diagnostics Centers
    • 5.3.2 Home Care
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 US
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 UK
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East and Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle East and Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Siemens AG
    • 6.1.2 Quest Diagnostics Inc.
    • 6.1.3 Hologic, Inc.
    • 6.1.4 F. Hoffmann-La Roche AG
    • 6.1.5 Perkinelmer Inc.
    • 6.1.6 Alere Inc.
    • 6.1.7 GE Healthcare
    • 6.1.8 Becton, Dickinson and Company
    • 6.1.9 Abbott Laboratories
    • 6.1.10 Biomerieux SA
    • 6.1.11 Koninklijke Philips N.V.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS